Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ILUVIEN in Pediatric Non-infectious Uveitis
NCT06539481Phase 4Recruiting
- Sponsor
- Alimera Sciences
- Start
- Aug 2024
- Primary completion
- Jul 2026
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 4 trial of fluocinolone in non-infectious posterior uveitis (NIPU), sponsored by Alimera Sciences. Started Aug 2024; status: recruiting.
02
Drugs
fluocinolone
03
Conditions
non-infectious posterior uveitis (NIPU)
Beyond the preview
Go deeper on NCT06539481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06539481.